Real
Health Care · Precision Medicine
Facts
as of Nov 20, 2026Exvade transforms cancer treatment by guiding invasive tumor cells into a controllable reservoir for safe removal and real-time analysis—unlocking new possibilities in precision oncology and targeted drug delivery.
- Headquarters
- Atlanta, United States
- Employees
- 51-200estimated range
- Website
- exvadebio.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Funding
Full ledger, 2 records →Real: 2 money records, each linked to its source.
$2.4MPublic grants2 public grants
Money innewest first
$2MPaid
$399kPaid
Money by yearUSD, rounds and grants
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Atlanta United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Milestones
Sep 10, 2024
Won a grant $2M · CORDIS
Aug 1, 2023
Won a grant $399k · CORDIS
Each milestone is dated by its source: registers, filings, the press
